Diagnostic approach to the etiology of recurrent pneumonia in children

Taha Özçelik1, Sinem Can Oksay2, Saniye Girit2

  • 1Department of Pediatrics, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Pediatric Pulmonology
|September 18, 2024
PubMed

Insights

Recurrent pneumonia (RP) in children has various causes, often linked to neuromuscular diseases or structural lung issues. Identifying these factors is key for effective treatment and prevention.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Recurrent pneumonia (RP) affects 7.7%-9% of pediatric pneumonia cases.
  • Identifying RP etiology is crucial for infection control and reducing morbidity/mortality.

Purpose of the Study:

  • To investigate the etiology, risk factors, and diagnostic procedures for recurrent pneumonia in children.
  • To utilize a diagnostic algorithm based on literature review.

Main Methods:

  • Retrospective analysis of 250 RP patients (aged 0-18) from 2018-2021 using national health data.
  • Etiology and risk factors determined by RP occurrence in same or different anatomical areas.

Main Results:

  • RP identified in 14.4% of recurrent lower respiratory tract infections.
  • Underlying causes found in 89.6% of patients.
  • Different-area RP linked to neuromuscular diseases; same-area RP to asthma, RML syndrome, or structural defects. Malnutrition, smoke exposure, and prematurity were common risk factors.

Conclusions:

  • Systematic etiological investigations should consider patient population and geography.
  • Diagnostic algorithms differentiating same-area vs. different-area recurrence are beneficial.
  • The causal link between asthma and RP requires further clarification.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
308
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
230
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
126